LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in LENZ Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +9 vs. Q1 2025
- Shares held
- 24.7M
- +3.65M (+17.3%) vs. Q1 2025
- Total value
- $725.1M
- +$183.3M (+33.8%) vs. Q1 2025
- New holders
- 25
- 53 more added
- Sold out
- 16
- 15 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 416,122 | $12.2M | 0.00% | +55,730+15.5% | Added |
| Morgan Stanley | 585,355 | $17.2M | 0.00% | +396,611+210.1% | Added |
| Point72 Asset Management, L.P. | 618,142 | $18.1M | 0.04% | −234,102−27.5% | Reduced |
| RTW Investments, LP | 863,389 | $25.3M | 0.36% | 00.0% | Unchanged |
| UBS Group AG | 881,481 | $25.8M | 0.01% | +214,317+32.1% | Added |
| Tang Capital Management LLC | 897,616 | $26.3M | 1.33% | +130,676+17.0% | Added |
| Sectoral Asset Management Inc | 977,245 | $28.6M | 18.91% | 00.0% | Unchanged |
| 72 Investment Holdings, LLC | 1,017,751 | $29.8M | 77.84% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,122,738 | $32.9M | 0.06% | +585,000+108.8% | Added |
| Vanguard Group Inc | 1,290,994 | $37.8M | 0.00% | +91,532+7.6% | Added |
| BlackRock, Inc. | 1,432,461 | $42.0M | 0.00% | +265,944+22.8% | Added |
| Paradigm Biocapital Advisors LP | 1,717,066 | $50.3M | 2.15% | +205,134+13.6% | Added |
| Falcon Edge Capital, LP | 3,612,211 | $105.9M | 11.41% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,178,823 | $122.5M | 2.06% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −42,230−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −34,828−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −27,829−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −27,569−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −22,933−100.0% | Sold out |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −10,159−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −8,322−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −6,154−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |